<?xml version="1.0" encoding="UTF-8"?>
<p>From our results we conclude that directly observed DAA therapy along with OST might be an efficient strategy to achieve SVR rates comparable to patients without a history of IDU in PWIDs with high risk of non-adherence to DAA therapy even in the presence of ongoing IDU. This concept represents a relevant public health strategy in the attempt to eliminate hepatitis C in Austria.</p>
